Notice: This company has been marked as potentially delisted and may not be actively trading. HealthCor Catalio Acquisition (HCAQ) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends HCAQ vs. CHEK, HOLX, BFLY, ONCY, IVCP, AVTE, IMAB, OVID, ZIVO, and PIIIShould you be buying HealthCor Catalio Acquisition stock or one of its competitors? The main competitors of HealthCor Catalio Acquisition include Check-Cap (CHEK), Hologic (HOLX), Butterfly Network (BFLY), Oncolytics Biotech (ONCY), Swiftmerge Acquisition (IVCP), Aerovate Therapeutics (AVTE), I-Mab (IMAB), Ovid Therapeutics (OVID), ZIVO Bioscience (ZIVO), and P3 Health Partners (PIII). These companies are all part of the "medical" sector. HealthCor Catalio Acquisition vs. Check-Cap Hologic Butterfly Network Oncolytics Biotech Swiftmerge Acquisition Aerovate Therapeutics I-Mab Ovid Therapeutics ZIVO Bioscience P3 Health Partners Check-Cap (NASDAQ:CHEK) and HealthCor Catalio Acquisition (NASDAQ:HCAQ) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, community ranking, earnings, risk, institutional ownership, dividends and valuation. Does the media refer more to CHEK or HCAQ? In the previous week, Check-Cap had 1 more articles in the media than HealthCor Catalio Acquisition. MarketBeat recorded 1 mentions for Check-Cap and 0 mentions for HealthCor Catalio Acquisition. Check-Cap's average media sentiment score of 0.00 equaled HealthCor Catalio Acquisition'saverage media sentiment score. Company Overall Sentiment Check-Cap Neutral HealthCor Catalio Acquisition Neutral Is CHEK or HCAQ more profitable? Company Net Margins Return on Equity Return on Assets Check-CapN/A N/A N/A HealthCor Catalio Acquisition N/A N/A N/A Do insiders & institutionals have more ownership in CHEK or HCAQ? 1.1% of Check-Cap shares are held by institutional investors. Comparatively, 84.2% of HealthCor Catalio Acquisition shares are held by institutional investors. 0.5% of Check-Cap shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has stronger earnings & valuation, CHEK or HCAQ? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCheck-CapN/AN/A-$17.57M-$3.00-0.27HealthCor Catalio AcquisitionN/AN/AN/AN/AN/A Does the MarketBeat Community believe in CHEK or HCAQ? Check-Cap received 370 more outperform votes than HealthCor Catalio Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformCheck-CapOutperform Votes37063.14% Underperform Votes21636.86% HealthCor Catalio AcquisitionN/AN/A SummaryCheck-Cap beats HealthCor Catalio Acquisition on 3 of the 4 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Get HealthCor Catalio Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for HCAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCAQ vs. The Competition Export to ExcelMetricHealthCor Catalio AcquisitionX IndustryMedical SectorNASDAQ ExchangeMarket Cap$19.18M$6.33B$5.10B$8.84BDividend YieldN/AN/A5.04%4.07%P/E RatioN/A23.6695.6214.26Price / SalesN/A7.551,217.1987.73Price / CashN/A14.2839.5936.27Price / BookN/A2.546.946.36Net IncomeN/A$212.74M$118.89M$225.56M HealthCor Catalio Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCAQHealthCor Catalio AcquisitionN/A$0.90+3.4%N/A-29.9%$19.18MN/A0.002High Trading VolumeCHEKCheck-Cap0.5192 of 5 stars$0.80+5.0%N/A-76.9%$4.68MN/A-0.2780Upcoming EarningsNews CoverageGap UpHOLXHologic4.8724 of 5 stars$78.62+0.7%$89.91+14.4%+8.5%$18.26B$4.03B23.666,990BFLYButterfly Network1.1789 of 5 stars$3.31-0.3%$3.00-9.4%+212.2%$705.23M$65.90M-7.67460ONCYOncolytics Biotech1.2531 of 5 stars$0.99-1.2%$4.00+305.4%-37.2%$76.05MN/A0.0030Analyst RevisionIVCPSwiftmerge AcquisitionN/A$11.08+0.1%N/A+5.1%$75.79MN/A0.002,021News CoverageAVTEAerovate Therapeutics1.7329 of 5 stars$2.61-1.9%$2.25-13.8%-81.7%$75.38MN/A0.0051Positive NewsIMABI-Mab2.5449 of 5 stars$0.92-5.7%$8.00+765.2%-37.6%$75.29M$3.89M0.0034OVIDOvid Therapeutics4.4265 of 5 stars$1.06+1.4%$4.04+282.9%-68.5%$74.92M$390,000.00-2.2160Analyst RevisionNews CoverageZIVOZIVO BioscienceN/A$21.00+0.2%N/A+1,668.8%$74.55M$30,000.000.0010Negative NewsPIIIP3 Health Partners3.2703 of 5 stars$0.21+1.0%$2.38+1,053.5%-82.9%$73.66M$1.27B0.00500Analyst ForecastAnalyst Revision Related Companies and Tools Related Companies CHEK Competitors HOLX Competitors BFLY Competitors ONCY Competitors IVCP Competitors AVTE Competitors IMAB Competitors OVID Competitors ZIVO Competitors PIII Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HCAQ) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HealthCor Catalio Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share HealthCor Catalio Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
